Thus far, the effect of tirzepatide on cardiovascular risk factors has indicated improvements in lipids, lipoprotein profiles, glucose control, body weight, blood pressure, and several biomarkers of inflammation in adults with overweight or obesity both with and without T2D (Tables 1, 2, 3, 4)
Available from: Ormazabal, V
Case 3: Chronic Shoulder Tendinopathy (Swimmer) Situation : 18 months rotator cuff inflammation, limited overhead motion Protocol : BPC-157: 250mcg daily for 12 weeks Physical therapy 2x weekly Dry needling and myofascial release Result : 70% improvement in overhead strength and range of motion by week 8
and silydianin (about 10%), along with minor amounts of isosilybin and other isomers [1][5][6]
Aktham is a recipient of the ACS Heroes of Chemistry Award and has authored more than 80 journal articles, book chapters, patents/applications, and conference proceedings
These alternatives to branded GLP-1s require a prescription